Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Moderna Inc (NQ: MRNA )

104.91 +1.05 (+1.01%)
Streaming Delayed Price Updated: 3:24 PM EDT, Apr 16, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,538,921
Open 102.08
Bid (Size) 104.81 (4)
Ask (Size) 104.93 (1)
Prev. Close 103.86
Today's Range 101.30 - 106.42
52wk Range 62.55 - 156.75
Shares Outstanding 382,000,000
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Johnson & Johnson Shows Focus On Strengthening Its Business Upon Its Consumer Health Unit Spinoff
On Tuesday, Johnson & Johnson (NYSE: JNJ) delivered a rather mixed first quarter report. Adjusted earnings surpassed estimates as sales in its medical devices business surged, while revenue was almost... 
Via Benzinga
2 Artificial Intelligence (AI) in Healthcare Stocks to Buy and Hold for Great Long-Term Potential
These companies have gotten in on AI early and could emerge as winners. 
Via The Motley Fool
Topics Artificial Intelligence
Exposures Artificial Intelligence

Performance

YTD
-6.75%
-6.75%
1 Month
+0.62%
+0.62%
3 Month
+2.69%
+2.69%
6 Month
+14.11%
+14.11%
1 Year
-27.13%
-27.13%

More News

Read More
2 Stocks Down 30% to Buy Right Now
Via The Motley Fool
Bill Gates Called For A 'Universal Flu Vaccine,' Now The CDC Director Says The Organization Is 'Activated' After Issuing Bird Flu Alert
Via Benzinga
1 New Green Flag for Moderna and Merck Stock
Via The Motley Fool
$1000 Invested In Moderna 5 Years Ago Would Be Worth This Much Today
Via Benzinga
A Closer Look at Moderna's Options Market Dynamics
Via Benzinga
Moderna Inc. (NASDAQ: MRNA) Leading the Way in Tuesday Trading Based on Percentage Gain
Via Investor Brand Network
3 Pharma Stocks to Sell in April Before They Crash & Burn
Via InvestorPlace
If You Can Only Buy One Biotech Stock in April, It Better Be One of These 3 Names
Via InvestorPlace
Declining COVID-19 Vaccine Sales Pinches Moderna, Pauses Kenya Vaccine Plant Plans
Via Benzinga
Exposures COVID-19
The Pharmaceutical Industry Finds Itself At A Historical Crossroads
Via Benzinga
Election Year Encore: Can 2020’s Top 7 Stock Winners Repeat Their Performance in 2024?
Via InvestorPlace
Why Is Moderna Stock Trading Higher On Tuesday?
Via Benzinga
Stocks Fall Ahead Of Key Inflation Data, Gold Defends Record Highs; Bitcoin Stumbles Below $70,000: What's Driving Markets Tuesday?
Via Benzinga
Topics Economy
Exposures Interest Rates
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
BlackBerry, Nurix Therapeutics, Tesla And Other Big Stocks Moving Higher On Tuesday
Via Benzinga
Topics Stocks
Exposures US Equities
Why Tilray Brands Shares Are Trading Lower By Around 22%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
Missed Out on Eli Lilly? 2 Healthcare Stocks With Big Catalysts on the Horizon.
Via The Motley Fool
Bull Market and Beyond: 3 Stocks Just Waiting to Soar
Via The Motley Fool
3 Healthcare Stocks Short Sellers Are Prescribing for Trouble
Via InvestorPlace
Moderna's Vaccines Day 2024: A Glimpse into the Future of Infectious Disease Prevention
Via Benzinga
The 3 Most Undervalued Biotech Stocks to Buy in April 2024
Via InvestorPlace
Arbutus Vs. Moderna Patent Dispute Over Covid-19 Vaccine Gets Response From Judge
Via Benzinga
Topics Intellectual Property
Exposures COVID-19 Intellectual Property
Moderna Shares Slip Over Covid Vaccine Patent Dispute, But Chart Signals Potential Rebound Ahead
Via Benzinga
Topics Intellectual Property
Exposures COVID-19 Intellectual Property
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.